EyeD Pharma: Clinical Trials

2 trials sponsored by EyeD Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 1, Terminated 1
Phase 21Recruiting 1

Follow EyeD Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
TimoD implant, Injector system, Timolol eye drops 0.5% - Glaucoma, Ocular Hypertension
Phase 1 / Phase 2RecruitingEyeD Pharma422025-06-122026-07-30
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
TimoD implant, Injector system - Primary Open-angle Glaucoma
Phase 1TerminatedEyeD Pharma12023-03-012025-07-16

Conditions studied

Glaucoma (2)  ·  Cataract (1)  ·  Glaucoma, Open-Angle (1)  ·  Lens Diseases (1)  ·  Ocular Hypertension (1)

Interventions

Drugs, Investigational (2)

Countries

Germany (1)  ·  Panama (1)